| Symbol |
Name |
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABR
|
active BCR-related
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP4
|
aquaporin 4
|
|
AQP6
|
aquaporin 6, kidney specific
|
|
AR
|
androgen receptor
|
|
ARTN
|
artemin
|
|
ASL
|
argininosuccinate lyase
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNH
|
cyclin H
|
|
CD163
|
CD163 molecule
|
|
CD274
|
CD274 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
COX2
|
|
|
COX8A
|
cytochrome c oxidase subunit VIIIA (ubiquitous)
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DCTN6
|
dynactin 6
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4A1
|
eukaryotic translation initiation factor 4A1
|
|
EIF4A2
|
eukaryotic translation initiation factor 4A2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ENG
|
endoglin
|
|
EPHB2
|
EPH receptor B2
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FSD1
|
fibronectin type III and SPRY domain containing 1
|
|
FSD1L
|
fibronectin type III and SPRY domain containing 1-like
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HMHB1
|
histocompatibility (minor) HB-1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IL34
|
interleukin 34
|
|
IL6
|
interleukin 6
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
KARS1
|
lysyl-tRNA synthetase 1
|
|
KLF11
|
Kruppel-like factor 11
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT81
|
keratin 81, type II
|
|
KRT86
|
keratin 86, type II
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LIMK1
|
LIM domain kinase 1
|
|
LZTR1
|
leucine-zipper-like transcription regulator 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIB1
|
mindbomb E3 ubiquitin protein ligase 1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NRTN
|
neurturin
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PEG10
|
paternally expressed 10
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMG8
|
SMG8 nonsense mediated mRNA decay factor
|
|
SMS
|
spermine synthase
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TMED7
|
transmembrane emp24 protein transport domain containing 7
|
|
TMED7-TICAM2
|
TMED7-TICAM2 readthrough
|
|
TMEM165
|
transmembrane protein 165
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WT1
|
Wilms tumor 1
|
|
ZAR1
|
zygote arrest 1
|
